332 related articles for article (PubMed ID: 27704252)
1. Extrarenal effects of FGF23.
Haffner D; Leifheit-Nestler M
Pediatr Nephrol; 2017 May; 32(5):753-765. PubMed ID: 27704252
[TBL] [Abstract][Full Text] [Related]
2. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
[TBL] [Abstract][Full Text] [Related]
3. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
Lacroix JS; Urena-Torres P
Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
[TBL] [Abstract][Full Text] [Related]
4. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
5. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
[TBL] [Abstract][Full Text] [Related]
6. FGF23 and Klotho in chronic kidney disease.
Olauson H; Larsson TE
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
Nitta K; Nagano N; Tsuchiya K
Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
[TBL] [Abstract][Full Text] [Related]
8. FGF23 and Phosphate-Cardiovascular Toxins in CKD.
Vogt I; Haffner D; Leifheit-Nestler M
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31698866
[TBL] [Abstract][Full Text] [Related]
9. FGF23 from bench to bedside.
Kovesdy CP; Quarles LD
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1168-74. PubMed ID: 26864938
[TBL] [Abstract][Full Text] [Related]
10. Paracrine Effects of FGF23 on the Heart.
Leifheit-Nestler M; Haffner D
Front Endocrinol (Lausanne); 2018; 9():278. PubMed ID: 29892269
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density.
Hensel N; Schön A; Konen T; Lübben V; Förthmann B; Baron O; Grothe C; Leifheit-Nestler M; Claus P; Haffner D
J Neurochem; 2016 Jun; 137(5):756-69. PubMed ID: 26896818
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
14. The role of fibroblast growth factor-23 in cardiorenal syndrome.
Kovesdy CP; Quarles LD
Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
[TBL] [Abstract][Full Text] [Related]
15. FGF23: a mature renal and cardiovascular risk factor?
Zoccali C; Yilmaz MI; Mallamaci F
Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
[TBL] [Abstract][Full Text] [Related]
16. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
Gan L; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor-23-A Potential Uremic Toxin.
Kuczera P; Adamczak M; Wiecek A
Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27941640
[TBL] [Abstract][Full Text] [Related]
18. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
Xie J; Yoon J; An SW; Kuro-o M; Huang CL
J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
[TBL] [Abstract][Full Text] [Related]
19. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
Kondo Y; Komaba H; Fukagawa M
Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
[TBL] [Abstract][Full Text] [Related]
20. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]